Fan Nation
Forums
Forum list
Search forums
Rules & Policies
Podcast
Mobile App
Media
New media
New comments
Search media
Shop
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
Forum list
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Horned Frog Athletics
Scott & Wes Frog Fan Forum
CWS Game Thread: TCU vs. Coastal Carolina (Tuesday, 8 pm)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tcudoc" data-source="post: 2220489" data-attributes="member: 44"><p>For Micah's parents. I am not an expert on this, but may be worth considering to ease Micah's pain. It is a well established treatment of this type of pain. Probably worth asking Micah's doctor about. He may or may not be a good candidate, depending on many different circumstances.</p><p> </p><p></p><p></p><p> Strontium 89 for Palliation of Bone Metastases</p><p></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Reddy%20EK%5Bauth%5D" target="_blank">Eashwer K. Reddy</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Robinson%20RG%5Bauth%5D" target="_blank">Ralph G. Robinson</a>, and <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mansfield%20CM%5Bauth%5D" target="_blank">Carl M. Mansfield</a></p><p></p><p></p><p> </p><p><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571189/#" target="_blank">Copyright and License information ►</a></p><p> </p><p></p><p></p><p></p><p></p><p></p><p></p><p> Abstract</p><p>At the University of Kansas Medical Center, systemic use of strontium 89 ([SIZE=.8461em]89[/SIZE]Sr), a betaemitting radioisotope, was evaluated in the treatment of metastatic carcinoma to bone for relief of bone pain. Eighty-five patients were treated with systemic [SIZE=.8461em]89[/SIZE]Sr in the dosage of 30 to 40 μCi/kg. All patients had multiple bone metastases, the majority with primary breast or prostatic cancer. The response to treatment was evaluated by daily diary entries, changes in the amount of pain medication, periodic bone scans, and other laboratory values.</p><p>In the patients who survived (47) and who were observed for three or more months, overall results showed 15 percent becoming pain free; 23 percent showed marked improvement with decreased consumption of pain medication; 53 percent showed mild but significant improvement in pain relief and decrease in pain medication requirement; and 9 percent showed no improvement. No patients noted a worsening of bone pain after the treatment. There was a combined favorable response in 91 percent (43/47) of patients with some meaningful palliation after [SIZE=.8461em]89[/SIZE]Sr therapy. This study, using [SIZE=.8461em]89[/SIZE]Sr systemic therapy, suggests that this isotope may be a valuable adjuvant therapy for palliation of pain from metastatic bone lesions.</p></blockquote><p></p>
[QUOTE="tcudoc, post: 2220489, member: 44"] For Micah's parents. I am not an expert on this, but may be worth considering to ease Micah's pain. It is a well established treatment of this type of pain. Probably worth asking Micah's doctor about. He may or may not be a good candidate, depending on many different circumstances. Strontium 89 for Palliation of Bone Metastases [URL="http://www.ncbi.nlm.nih.gov/pubmed/?term=Reddy%20EK%5Bauth%5D"]Eashwer K. Reddy[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed/?term=Robinson%20RG%5Bauth%5D"]Ralph G. Robinson[/URL], and [URL="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mansfield%20CM%5Bauth%5D"]Carl M. Mansfield[/URL] [URL="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571189/#"]Copyright and License information ►[/URL] Abstract At the University of Kansas Medical Center, systemic use of strontium 89 ([SIZE=.8461em]89[/SIZE]Sr), a betaemitting radioisotope, was evaluated in the treatment of metastatic carcinoma to bone for relief of bone pain. Eighty-five patients were treated with systemic [SIZE=.8461em]89[/SIZE]Sr in the dosage of 30 to 40 μCi/kg. All patients had multiple bone metastases, the majority with primary breast or prostatic cancer. The response to treatment was evaluated by daily diary entries, changes in the amount of pain medication, periodic bone scans, and other laboratory values. In the patients who survived (47) and who were observed for three or more months, overall results showed 15 percent becoming pain free; 23 percent showed marked improvement with decreased consumption of pain medication; 53 percent showed mild but significant improvement in pain relief and decrease in pain medication requirement; and 9 percent showed no improvement. No patients noted a worsening of bone pain after the treatment. There was a combined favorable response in 91 percent (43/47) of patients with some meaningful palliation after [SIZE=.8461em]89[/SIZE]Sr therapy. This study, using [SIZE=.8461em]89[/SIZE]Sr systemic therapy, suggests that this isotope may be a valuable adjuvant therapy for palliation of pain from metastatic bone lesions. [/QUOTE]
Verification
Which team did TCU defeat in the College Football Playoffs?
Post reply
Forums
Horned Frog Athletics
Scott & Wes Frog Fan Forum
CWS Game Thread: TCU vs. Coastal Carolina (Tuesday, 8 pm)
Top